Listening to the bladder field: Urine liquid biopsies reveal differential treatment responses in NMIBC.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41720073.
- Also identified by DOI 10.1016/j.cell.2026.01.019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue of Cell, Shi and colleagues introduce a urine-based liquid biopsy approach that reshapes how treatment response in NMIBC is assessed. They use urine tumor DNA to detect minimal residual disease and disentangle the contributions of surgery and immunotherapy to disease control, with implications extending beyond bladder cancer.
Medical subject headings
- Urinary Bladder Neoplasms